{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "KeywordList": [["Dry eye disease", "dry eye signs", "dry eye symptoms", "environmental factors", "ocular lubricants"]], "OtherID": [], "PMID": "39233999", "DateRevised": {"Year": "2024", "Month": "09", "Day": "07"}, "Article": {"ELocationID": ["10.2147/OPTH.S480223"], "ArticleDate": [{"Year": "2024", "Month": "08", "Day": "30"}], "Language": ["eng"], "Journal": {"ISSN": "1177-5467", "JournalIssue": {"Volume": "18", "PubDate": {"Year": "2024"}}, "Title": "Clinical ophthalmology (Auckland, N.Z.)", "ISOAbbreviation": "Clin Ophthalmol"}, "ArticleTitle": "Influence of Environmental Factors with Clinical Signs and Symptoms in the Management of Dry Eye Disease.", "Pagination": {"StartPage": "2439", "EndPage": "2451", "MedlinePgn": "2439-2451"}, "Abstract": {"AbstractText": ["This research aims to investigate the influence of environmental factors on the treatment efficacy of ocular lubricants in patients from urban areas with dry eye disease (DED).", "A phase IV clinical trial, which included 173 patients from major cities in Mexico, was randomly assigned to use ocular lubricants four times a day for 30 days. Ocular Surface Disease Index (OSDI), noninvasive tear film break-up time (NIBUT), ocular staining, and conjunctival hyperemia (CH) among other factors like weather, and air pollution as covariates were analysed.", "After 30 days, OSDI score decreased by 14.8 points (<i>p</i><0.001), and NIBUT increased by 2.9 seconds (<i>p</i>< 0.001), with longer values observed in patients recruited in autumn and winter (additional 1.8 seconds, <i>p</i>< 0.05) compared to those recruited in spring. Patients living in cities with cooler weather and high humidity, but low air quality had higher OSDI and conjunctival stain scores of up to 4.4 and 0.3 points, respectively, as compared to those living in cities with similar pollution and humidity levels but with higher temperatures (<i>p</i>-values= 0.019 and 0.050). Patients with moderate CH had an increase of up to 0.8 points in their corneal stain score (<i>p</i>< 0.010). We also found that ozone levels were related to the predicted changes in OSDI and NIBUT.", "This study demonstrated the impact of environmental factors on the signs and symptoms of DED and suggests that patients residing in cities with inadequately controlled air pollution can benefit from using ocular lubricants to alleviate their symptoms.", "Trial is registered at clinicaltrials.gov (NCT04702776)."], "CopyrightInformation": "\u00a9 2024 Mu\u00f1oz-Villegas et al."}, "AuthorList": [{"Identifier": ["0000-0002-7559-1218"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Regional Medical Affairs Department, Laboratorios Sophia, S.A. de C.V., Zapopan, Jalisco, Mexico."}, {"Identifier": [], "Affiliation": "Centro de Investigaci\u00f3n en Matem\u00e1ticas, A.C., Unidad Aguascalientes (CIMAT), Aguascalientes, Aguascalientes, Mexico."}], "LastName": "Mu\u00f1oz-Villegas", "ForeName": "Patricia", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Regional Medical Affairs Department, Laboratorios Sophia, S.A. de C.V., Zapopan, Jalisco, Mexico."}], "LastName": "Garc\u00eda-S\u00e1nchez", "ForeName": "Gisela", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Regional Medical Affairs Department, Laboratorios Sophia, S.A. de C.V., Zapopan, Jalisco, Mexico."}], "LastName": "Jauregui-Franco", "ForeName": "Ricardo O", "Initials": "RO"}, {"Identifier": ["0009-0004-2730-4343"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Regional Medical Affairs Department, Laboratorios Sophia, S.A. de C.V., Zapopan, Jalisco, Mexico."}], "LastName": "Quirarte-Justo", "ForeName": "Sebastian", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Regional Medical Affairs Department, Laboratorios Sophia, S.A. de C.V., Zapopan, Jalisco, Mexico."}], "LastName": "S\u00e1nchez-R\u00edos", "ForeName": "Alejandra", "Initials": "A"}, {"Identifier": ["0000-0003-2717-349X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Regional Medical Affairs Department, Laboratorios Sophia, S.A. de C.V., Zapopan, Jalisco, Mexico."}], "LastName": "Olvera-Monta\u00f1o", "ForeName": "Oscar", "Initials": "O"}], "DataBankList": [{"DataBankName": "ClinicalTrials.gov", "AccessionNumberList": ["NCT04702776"]}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Clin Ophthalmol", "NlmUniqueID": "101321512", "ISSNLinking": "1177-5467"}, "CoiStatement": "PMV, GGS, ROJF, SQJ, ASR and OOM are employees of Laboratorios Sophia, S.A. de C.V. The sponsor provided support in the form of salaries for the authors. This does not alter adherence to the Good Publication Practice guidelines for pharmaceutical companies (GPP3) policies on sharing data and materials. The authors report no other conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int. 2015;112(5):71\u201381;quiz82. doi:10.3238/arztebl.2015.0071", "ArticleIdList": ["10.3238/arztebl.2015.0071", "PMC4335585", "25686388"]}, {"Citation": "Kumar NR, Praveen M, Narasimhan R, et al. Tear biomarkers in dry eye disease: progress in the last decade. Indian J Ophthalmol. 2023;71(4):1190\u20131202. doi:10.4103/IJO.IJO_2981_22", "ArticleIdList": ["10.4103/IJO.IJO_2981_22", "PMC10276712", "37026250"]}, {"Citation": "Greiner JV, Ying GS, Pistilli M, Maguire MG, Asbell PA. Association of tear osmolarity with signs and symptoms of dry eye disease in the dry eye assessment and management (DREAM) study. Investigat Opthalmol Vis Sci. 2023;64(1):5. doi:10.1167/iovs.64.1.5", "ArticleIdList": ["10.1167/iovs.64.1.5", "PMC9838582", "36626176"]}, {"Citation": "Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276\u2013283. doi:10.1016/j.jtos.2017.05.008", "ArticleIdList": ["10.1016/j.jtos.2017.05.008", "28736335"]}, {"Citation": "Lemp MA, Foulks GN The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop (2007). Ocul Surf. 2007;5(2):75\u201392. doi:10.1016/S1542-0124(12)70081-2", "ArticleIdList": ["10.1016/S1542-0124(12)70081-2", "17508116"]}, {"Citation": "Alves M, Asbell P, Dogru M, et al. TFOS lifestyle report: impact of environmental conditions on the ocular surface. Ocul Surf. 2023;29:1\u201352. doi:10.1016/j.jtos.2023.04.007", "ArticleIdList": ["10.1016/j.jtos.2023.04.007", "37062427"]}, {"Citation": "Epidemiology DE The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international dry eye workshop (2007). Ocul Surf. 2007;5(2):93\u2013107. doi:10.1016/S1542-0124(12)70082-4", "ArticleIdList": ["10.1016/S1542-0124(12)70082-4", "17508117"]}, {"Citation": "Patel S, Mittal R, Kumar N, Galor A. The environment and dry eye\u2014manifestations, mechanisms, and more. Frontiers in Toxicology. 2023;5. doi:10.3389/ftox.2023.1173683", "ArticleIdList": ["10.3389/ftox.2023.1173683", "PMC10482047", "37681211"]}, {"Citation": "Er\u00f8y \u00c5A, Utheim TP, Sundling V. Cross-sectional study exploring vision-related quality of life in dry eye disease in a Norwegian optometric practice. Optometry Vision Sci. 2023;100(10):679\u2013687. doi:10.1097/OPX.0000000000002058", "ArticleIdList": ["10.1097/OPX.0000000000002058", "PMC10662625", "37751404"]}, {"Citation": "Mu\u00f1oz-Villegas P, S\u00e1nchez-R\u00edos A, Olvera-Monta\u00f1o O. The effect of sodium hyaluronate eye drops 2, 4 or 6 times a day on signs and symptoms of dry eye disease. Clin Ophthalmol. 2023;17:2945\u20132955. doi:10.2147/OPTH.S433709", "ArticleIdList": ["10.2147/OPTH.S433709", "PMC10563771", "37822327"]}, {"Citation": "Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334\u2013365. doi:10.1016/j.jtos.2017.05.003", "ArticleIdList": ["10.1016/j.jtos.2017.05.003", "28736337"]}, {"Citation": "Sivakumar GK, Patel J, Malvankar-Mehta MS, Mather R. Work productivity among Sj\u00f6gren\u2019s syndrome and non-Sj\u00f6gren\u2019s dry eye patients: a systematic review and meta-analysis. Eye. 2021;35(12):3243\u20133257. doi:10.1038/s41433-020-01282-3", "ArticleIdList": ["10.1038/s41433-020-01282-3", "PMC8602278", "33479487"]}, {"Citation": "Choi JH, Li Y, Kim SH, et al. The influences of smartphone use on the status of the tear film and ocular surface. PLoS One. 2018;13(10):e0206541. doi:10.1371/journal.pone.0206541", "ArticleIdList": ["10.1371/journal.pone.0206541", "PMC6209417", "30379901"]}, {"Citation": "Uchino M, Yokoi N, Uchino Y, et al. Prevalence of dry eye disease and its risk factors in visual display terminal users: the Osaka study. Am J Ophthalmol. 2013;156(4):759\u2013766.e1. doi:10.1016/j.ajo.2013.05.040", "ArticleIdList": ["10.1016/j.ajo.2013.05.040", "23891330"]}, {"Citation": "Mandell JT, Idarraga M, Kumar N, Galor A. Impact of air pollution and weather on dry eye. J Clin Med. 2020;9(11):3740. doi:10.3390/jcm9113740", "ArticleIdList": ["10.3390/jcm9113740", "PMC7699870", "33233863"]}, {"Citation": "Calonge M, Labetoulle M, Messmer EM, et al. Controlled adverse environment chambers in dry eye research. Curr Eye Res. 2018;43(4):445\u2013450. doi:10.1080/02713683.2017.1420197", "ArticleIdList": ["10.1080/02713683.2017.1420197", "29336696"]}, {"Citation": "Tes\u00f3n M, Gonz\u00e1lez-Garc\u00eda MJ, L\u00f3pez-Miguel A, et al. Influence of a controlled environment simulating an in-flight airplane cabin on dry eye disease. Investigat Opthalmol Vis Sci. 2013;54(3):2093. doi:10.1167/iovs.12-11361", "ArticleIdList": ["10.1167/iovs.12-11361", "23412090"]}, {"Citation": "Hwang SH, Choi YH, Paik HJ, Wee WR, Kim MK, Kim DH. Potential importance of ozone in the association between outdoor air pollution and dry eye disease in South Korea. JAMA Ophthalmol. 2016;134(5):503. doi:10.1001/jamaophthalmol.2016.0139", "ArticleIdList": ["10.1001/jamaophthalmol.2016.0139", "26967354"]}, {"Citation": "Santos NV, Yariwake VY, Marques KD, Veras MM, Fajersztajn L. Air pollution: a neglected risk factor for dementia in Latin America and the Caribbean. Front Neurol. 2021;12. doi:10.3389/fneur.2021.684524", "ArticleIdList": ["10.3389/fneur.2021.684524", "PMC8339300", "34367051"]}, {"Citation": "van Setten G, Labetoulle M, Baudouin C, Rolando M. Evidence of seasonality and effects of psychrometry in dry eye disease. Acta Ophthalmol. 2016;94(5):499\u2013506. doi:10.1111/aos.12985", "ArticleIdList": ["10.1111/aos.12985", "27105776"]}, {"Citation": "Kumar N, Feuer W, Lanza NL, Galor A. Seasonal Variation in Dry Eye. Ophthalmology. 2015;122(8):1727\u20131729. doi:10.1016/j.ophtha.2015.02.013", "ArticleIdList": ["10.1016/j.ophtha.2015.02.013", "PMC4757523", "25912217"]}, {"Citation": "Ayaki M, Kawashima M, Uchino M, Tsubota K, Negishi K. Possible association between subtypes of dry eye disease and seasonal variation. Clin Ophthalmol. 2017;11:1769\u20131775. doi:10.2147/OPTH.S148650", "ArticleIdList": ["10.2147/OPTH.S148650", "PMC5628676", "29033539"]}, {"Citation": "Asbell PA. Increasing importance of dry eye syndrome and the ideal artificial tear: consensus views from a roundtable discussion. Curr Med Res Opin. 2006;22(11):2149\u20132157. doi:10.1185/030079906X132640", "ArticleIdList": ["10.1185/030079906X132640", "17076975"]}, {"Citation": "P\u00e9rez-Balbuena AL, Ochoa-Tabares JC, Belalcazar-Rey S, et al. Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial. BMC Ophthalmol. 2016;16(1):164. doi:10.1186/s12886-016-0343-9", "ArticleIdList": ["10.1186/s12886-016-0343-9", "PMC5028962", "27645318"]}, {"Citation": "Belalc\u00e1zar-Rey S, S\u00e1nchez Huerta V, Ochoa-Tabares JC, et al. Efficacy and safety of sodium hyaluronate/chondroitin sulfate preservative-free ophthalmic solution in the treatment of dry eye: a clinical trial. Curr Eye Res. 2021;46(7):919\u2013929. doi:10.1080/02713683.2020.1849733", "ArticleIdList": ["10.1080/02713683.2020.1849733", "33289602"]}, {"Citation": "Semp DA, Beeson D, Sheppard AL, Dutta D, Wolffsohn JS. Artificial Tears: a Systematic Review. Clin Optom (Auckl). 2023;15:9\u201327. doi:10.2147/OPTO.S350185", "ArticleIdList": ["10.2147/OPTO.S350185", "PMC9840372", "36647552"]}, {"Citation": "Labetoulle M, Schmickler S, Galarreta D, et al. Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study. Clin Ophthalmol. 2018;12:2499\u20132508. doi:10.2147/OPTH.S177176", "ArticleIdList": ["10.2147/OPTH.S177176", "PMC6287663", "30584269"]}, {"Citation": "Alves-Concei\u00e7\u00e3o V, Rocha KSS, Silva FVN, et al. Are clinical outcomes associated with medication regimen complexity? A systematic review and meta-analysis. Ann Pharmacother. 2020;54(4):301\u2013313. doi:10.1177/1060028019886846", "ArticleIdList": ["10.1177/1060028019886846", "31718244"]}, {"Citation": "Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539\u2013574. doi:10.1016/j.jtos.2017.05.001", "ArticleIdList": ["10.1016/j.jtos.2017.05.001", "28736342"]}, {"Citation": "Willcox MDP, Arg\u00fceso P, Georgiev GA, et al. TFOS DEWS II tear film report. Ocul Surf. 2017;15(3):366\u2013403. doi:10.1016/j.jtos.2017.03.006", "ArticleIdList": ["10.1016/j.jtos.2017.03.006", "PMC6035753", "28736338"]}, {"Citation": "Singh S, Donthineni PR, Srivastav S, Jacobi C, Basu S, Paulsen F. Lacrimal and meibomian gland evaluation in dry eye disease: a mini-review. Indian J Ophthalmol. 2023;71(4):1090\u20131098. doi:10.4103/IJO.IJO_2622_22", "ArticleIdList": ["10.4103/IJO.IJO_2622_22", "PMC10276709", "37026239"]}, {"Citation": "Abdelfattah NS, Dastiridou A, Sadda SR, Lee OL. Noninvasive imaging of tear film dynamics in eyes with ocular surface disease. Cornea. 2015;34(Supplement 10):S48\u2013S52. doi:10.1097/ICO.0000000000000570", "ArticleIdList": ["10.1097/ICO.0000000000000570", "26226477"]}, {"Citation": "Singh RB, Liu L, Anchouche S, et al. Ocular redness \u2013 i: etiology, pathogenesis, and assessment of conjunctival hyperemia. Ocul Surf. 2021;21:134\u2013144. doi:10.1016/j.jtos.2021.05.003", "ArticleIdList": ["10.1016/j.jtos.2021.05.003", "PMC8328962", "34010701"]}, {"Citation": "Efron N. Grading scales for contact lens complications. Ophthalmic Physiol Opt. 1998;18(2):182\u2013186. doi:10.1016/S0275-5408(97)00066-5", "ArticleIdList": ["10.1016/S0275-5408(97)00066-5", "9692040"]}, {"Citation": "Chow SC, Wang H, Shao J. Sample Size Calculations in Clinical Research. Chapman and Hall/CRC; 2007; doi:10.1201/9781584889830", "ArticleIdList": ["10.1201/9781584889830"]}, {"Citation": "Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurements of dry eye. Cornea. 2004;23(3):272\u2013285. doi:10.1097/00003226-200404000-00010", "ArticleIdList": ["10.1097/00003226-200404000-00010", "15084861"]}, {"Citation": "Bui HL, Su YH, Yang CJ, Huang CJ, Lai JY. Mucoadhesive, antioxidant, and lubricant catechol-functionalized poly (phosphobetaine) as biomaterial nanotherapeutics for treating ocular dryness. J Nanobiotechnology. 2024;22(1):160. doi:10.1186/s12951-024-02448-x", "ArticleIdList": ["10.1186/s12951-024-02448-x", "PMC11000383", "38589911"]}, {"Citation": "Yang CJ, Anand A, Huang CC, Lai JY. Unveiling the power of gabapentin-loaded nanoceria with multiple therapeutic capabilities for the treatment of dry eye disease. ACS Nano. 2023;17(24):25118\u201325135. doi:10.1021/acsnano.3c07817", "ArticleIdList": ["10.1021/acsnano.3c07817", "38051575"]}, {"Citation": "Heilenbach N, Hu G, Lamrani R, et al. Environmental influences on ophthalmic conditions: a scoping review. Clin Exp Ophthalmol. 2023;51(6):516\u2013545. doi:10.1111/ceo.14262", "ArticleIdList": ["10.1111/ceo.14262", "37309709"]}, {"Citation": "Um SB, Kim NH, Lee HK, Song JS, Kim HC. Spatial epidemiology of dry eye disease: findings from South Korea. Int J Health Geogr. 2014;13(1):31. doi:10.1186/1476-072X-13-31", "ArticleIdList": ["10.1186/1476-072X-13-31", "PMC4139141", "25128034"]}, {"Citation": "Novaes P, Hil\u00e1rio Do Nascimento Saldiva P, Matsuda M, et al. The effects of chronic exposure to traffic derived air pollution on the ocular surface. Environ Res. 2010;110(4):372\u2013374. doi:10.1016/j.envres.2010.03.003", "ArticleIdList": ["10.1016/j.envres.2010.03.003", "20338555"]}, {"Citation": "Vehof J, Snieder H, Jansonius N, Hammond CJ. Prevalence and risk factors of dry eye in 79,866 participants of the population-based Lifelines cohort study in the Netherlands. Ocul Surf. 2021;19:83\u201393. doi:10.1016/j.jtos.2020.04.005", "ArticleIdList": ["10.1016/j.jtos.2020.04.005", "32376389"]}, {"Citation": "Kim Y, Choi YH, Kim MK, Paik HJ, Kim DH. Different adverse effects of air pollutants on dry eye disease: ozone, PM2.5, and PM10. Environ Pollut. 2020;265:115039. doi:10.1016/j.envpol.2020.115039", "ArticleIdList": ["10.1016/j.envpol.2020.115039", "32806456"]}, {"Citation": "Silva-Quiroz R, Rivera AL, Ordo\u00f1ez P, Gay-Garcia C, Frank A. Atmospheric blockages as trigger of environmental contingencies in Mexico City. Heliyon. 2019;5(7):e02099. doi:10.1016/j.heliyon.2019.e02099", "ArticleIdList": ["10.1016/j.heliyon.2019.e02099", "PMC6661268", "31372551"]}, {"Citation": "Hern\u00e1ndez Paniagua IY, Clemitshaw KC, Mendoza A. Observed trends in ground-level O3; in Monterrey, Mexico, during 1993\u20132014: comparison with Mexico City and Guadalajara. Atmos Chem Phys. 2017;17(14):9163\u20139185. doi:10.5194/acp-17-9163-2017", "ArticleIdList": ["10.5194/acp-17-9163-2017"]}, {"Citation": "Hao R, Zhang M, Zhao L, et al. Impact of air pollution on the ocular surface and tear cytokine levels: a multicenter prospective cohort study. Front Med Lausanne. 2022:9. doi:10.3389/fmed.2022.909330", "ArticleIdList": ["10.3389/fmed.2022.909330", "PMC9301315", "35872759"]}, {"Citation": "Sanchez MA, Torralbo-Jimenez P, Giron N, et al. Comparative analysis of carmellose 0.5% versus hyaluronate 0.15% in dry eye: a flow cytometric study. Cornea. 2010;29(2):167\u2013171. doi:10.1097/ICO.0b013e3181b11648", "ArticleIdList": ["10.1097/ICO.0b013e3181b11648", "20023577"]}, {"Citation": "Amrane M, Creuzot-Garcher C, Robert PY, et al. Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease \u2013 a randomised comparative study. J Fr Ophtalmol. 2014;37(8):589\u2013598. doi:10.1016/j.jfo.2014.05.001", "ArticleIdList": ["10.1016/j.jfo.2014.05.001", "25127703"]}, {"Citation": "Benelli U, Nardi M, Posarelli C, Albert TG. Tear osmolarity measurement using the TearLabTM Osmolarity System in the assessment of dry eye treatment effectiveness. Contact Lens Anterior Eye. 2010;33(2):61\u201367. doi:10.1016/j.clae.2010.01.003", "ArticleIdList": ["10.1016/j.clae.2010.01.003", "20153684"]}, {"Citation": "Abusharha AA, Pearce EI, Fagehi R. Effect of ambient temperature on the human tear film. Eye & Contact Lens. 2016;42(5):308\u2013312. doi:10.1097/ICL.0000000000000210", "ArticleIdList": ["10.1097/ICL.0000000000000210", "26595213"]}, {"Citation": "Song MS, Lee Y, Paik HJ, Kim DH. a comprehensive analysis of the influence of temperature and humidity on dry eye disease. Korean j Ophthalmol. 2023;37(6):501\u2013509. doi:10.3341/kjo.2023.0077", "ArticleIdList": ["10.3341/kjo.2023.0077", "PMC10721396", "37899282"]}, {"Citation": "Mendell MJ, Fisk WJ, Petersen MR, et al. Indoor particles and symptoms among office workers: results from a double-blind cross-over study. Epidemiology. 2002;13(3):296\u2013304. doi:10.1097/00001648-200205000-00010", "ArticleIdList": ["10.1097/00001648-200205000-00010", "11964931"]}, {"Citation": "Leonardi A, Modugno RL, Salami E. Allergy and dry eye disease. Ocul Immunol Inflamm. 2021;29(6):1168\u20131176. doi:10.1080/09273948.2020.1841804", "ArticleIdList": ["10.1080/09273948.2020.1841804", "33544639"]}, {"Citation": "Sullivan BD, Crews LA, Messmer EM, et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol. 2014;92(2):161\u2013166. doi:10.1111/aos.12012", "ArticleIdList": ["10.1111/aos.12012", "23279964"]}, {"Citation": "Chlasta-Twardzik E, G\u00f3recka-Nito\u0144 A, Nowi\u0144ska A, Wyl\u0119ga\u0142a E. The influence of work environment factors on the ocular surface in a one-year follow-up prospective clinical study. Diagnostics. 2021;11(3):392. doi:10.3390/diagnostics11030392", "ArticleIdList": ["10.3390/diagnostics11030392", "PMC7996489", "33668951"]}, {"Citation": "LWG OD, AKPEK EK. The negative effects of dry eye disease on quality of life and visual function. Turk J Med Sci. 2020;50(7):1611\u20131615. doi:10.3906/sag-2002-143", "ArticleIdList": ["10.3906/sag-2002-143", "PMC7672346", "32283910"]}, {"Citation": "Grubbs JR, Tolleson-Rinehart S, Huynh K, Davis RM. A review of quality of life measures in dry eye questionnaires. Cornea. 2014;33(2):215\u2013218. doi:10.1097/ICO.0000000000000038", "ArticleIdList": ["10.1097/ICO.0000000000000038", "PMC4201928", "24326332"]}, {"Citation": "Szczesna-Iskander DH, Muzyka-Wozniak M, Llorens Quintana C. The efficacy of ocular surface assessment approaches in evaluating dry eye treatment with artificial tears. Sci Rep. 2022;12(1):21835. doi:10.1038/s41598-022-26327-3", "ArticleIdList": ["10.1038/s41598-022-26327-3", "PMC9759550", "36528723"]}]}], "History": [{"Year": "2024", "Month": "7", "Day": "23"}, {"Year": "2024", "Month": "8", "Day": "19"}, {"Year": "2024", "Month": "9", "Day": "5", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "9", "Day": "5", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "9", "Day": "5", "Hour": "4", "Minute": "18"}, {"Year": "2024", "Month": "8", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["39233999", "PMC11372294", "10.2147/OPTH.S480223", "480223"]}}]}